BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION

Clinical trials for BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION explained in plain language.

Never miss a new study

Get alerted when new BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION trials appear

Sign up with your email to follow new studies for BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for transplant patients fighting a dangerous virus

Disease control Completed

This study tested if switching to a different immune-suppressing drug (everolimus) helps kidney transplant patients clear a common and dangerous virus (BK virus) from their blood. It compared this switch to the standard approach of just lowering their current immune-suppressing d…

Matched conditions: BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION

Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION

Get alerted when new BK VIRUS NEPHROPATHY AFTER KIDNEY TRANSPLANTATION trials appear

New hope for transplant patients fighting a dangerous virus